An observational study in Acute Coronary Syndrome, sponsored by Hospital Álvaro Cunqueiro. Status unknown at 1 site in Spain. Per ClinicalTrials.gov, last updated 2018-09-10.
Sponsored by Hospital Álvaro Cunqueiro · Observational
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 85 studies in Acute Coronary Syndrome with a site in Spain — 13 open to participants now, 16 under way, 1 of them phase 3. Acute Coronary Syndrome · Spain.
Among the 85 studies in Acute Coronary Syndrome with a site in Spain, this one is the 3rd largest by planned enrollment of the 25 observational ones that give a count, is one of 5 that started in 2016, is one of 25 observational ones, and was the 50th registered.
1,491 studies on the registry are indexed under Acute Coronary Syndrome; 272 are open to participants now.
Browse Acute Coronary Syndrome studies →13 of the 85 studies in Acute Coronary Syndrome with a site in Spain are open now. Recruiting first, the newest first:
Kristian Rivera · Sites in Spain, Mexico
Ages 18+
Instituto de Investigación Sanitaria de la Fundación Jiménez Díaz · Sites in Spain, Ireland, Latvia and 2 more countries
Ages 18+
Ceric Sàrl · Sites in Spain
Ages 18+
Fundación para la Investigación del Hospital Clínico de Valencia · Sites in Spain
Ages 65+
Abcentra · Sites in Spain, United States, Czechia and 6 more countries
Ages 18+
A study can be open while its sites in Spain have not opened yet or have stopped. Only those recruiting at a site in Spain →
Of the 195 Acute Coronary Syndrome studies recruiting now, 144 (74%) set no upper age limit and 19 (10%) stop at 75 or younger; 15 take children under 18; 15 take healthy volunteers.
This study: all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
85 studies; the count open now beside each. This study's row is marked.
First in 2003; this study’s year is marked. 5 started in 2016.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 8,000 is above the median of 500 across 590 observational studies indexed under Acute Coronary Syndrome.
Median enrollment 588 across the 60 interventional studies, 900 across the 25 observational. Of the 58 that completed or were terminated, 20 (34%) have results posted.
This tab as a report to print or save as PDF → With an account.
33 of 85 have an industry lead sponsor. The 10 most frequent:
Hospital Álvaro Cunqueiro is the lead sponsor of 3 studies on the registry; 1 is open to participants now.
Hospital Álvaro Cunqueiro has 1 study filed under Acute Coronary Syndrome — fewer than ten, so there is no comparison to draw.
5 of the studies in Acute Coronary Syndrome with a site in Spain that are under way reach primary completion within a year, 1 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07102628Phase 3Novartis PharmaceuticalsEvaluation of Efficacy and Safety of Early in Hospital Initiation of Inclisiran Treatment in Patients With Acute Coronary Syndromes | 2027-01-16 |
| NCT06736665Spanish Society of CardiologyOrbital Atherectomy vs Intravascular Lithotripsy for the Treatment of Calcified Coronary Nodules (ORBIT-SHOCK). | 2026-12 |
| NCT06927739AbcentraFocused Orticumab Research for Treating Inflammation in Coronary Arteries | 2027-02-08 |
| NCT07091682Biotronik AGSafety and Clinical Performance of the Freesolve Resorbable Magnesium Scaffold System in the Treatment of Subjects With Long de Novo Lesions | 2027-06 |
| NCT07038265Institut d'Investigació Biomèdica de BellvitgePatient-centered Personalized Cardiac Rehabilitation in Post Acute Coronary Syndrome (BREAK-trial) | 2027-11 |
Add all 5 to your calendar (.ics) → With an account.
Among the 85 studies in Acute Coronary Syndrome with a site in Spain, from their registry updates:
This tab as a report to print or save as PDF → With an account.
CardoCHUVI registry was aim to study ischemic and bleeding complication after an acute coronary syndrome (ACS), both in-hospital and follow-up events.
CardioCHUVI is a retrospective study aim to analyze all consecutively patients admitted by acute coronary syndrome to University Hospital Alvaro Cunqueiro of Vigo, between January 2010 to January 2018
The objective of the project was to study cardiac and bleeding complications, such as reinfarction, heart failure, atrial fibrillation, stroke, and bleeding events, together with all-cause and cardiac mortality
Consecutive patients admitted by acute coronary syndrome in the University Hospital Alvaro Cunqueiro of Vigo between January 2010 to January 2018
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Compare bleeding and ischemic events according to the type and duration of dual antiplatelet therapy
Also known as: Dual antiplatelet therapy with clopidogrel
All cause mortality
Death for any cause
Time frame: Through study completion, an average of 3 years
Reinfarction
New spontaneous acute myocardial infarction
Time frame: Through study completion, an average of 3 years
Bleeding
Any bleeding according to BARC definition (from 1 to 5)
Time frame: Through study completion, an average of 3 years
Ischemic stroke
Ischemic stroke documented in CT
Time frame: Through study completion, an average of 3 years
Cancer
Any type of malignant cancer
Time frame: Through study completion, an average of 3 years
Heart Failure
Heart Failure admissions
Time frame: Through study completion, an average of 3 years
Atrial Fibrillation
Atrial fibrillation documented in ECG
Time frame: Through study completion, an average of 3 years
Plan to share: No — Registry of all consecutive patients admitted by acute coronary syndrome (ACS) to an university hospital in order to analyze bleeding and ischemic complications according to the type and duration of dual antiplatelet therapy
No publications or documents are linked to this record.
Ran from Feb 2016 to primary completion in Sep 2018, 31 months.
How these figures are worked out, and which studies are left out of them.
This study is status unknown, as verified in Sep 2018. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Hospital Álvaro Cunqueiro